Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites.
about
Selective antagonism of the GABA(A) receptor by ciprofloxacin and biphenylacetic acidQuinolones potentiate cefazolin-induced seizures in DBA/2 miceAntimicrobial safety: focus on fluoroquinolonesInteraction between ciprofloxacin and thiopental in the central nervous system of the male ratInvolvement of inhibitory and excitatory neurotransmitters in levofloxacin- and ciprofloxacin-induced convulsions in miceA new approach for early assessment of the epileptogenic potential of quinolonesNeurotoxicodynamics of the interaction between ciprofloxacin and foscarnet in miceDo we need an intravenous fluoroquinolone?Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model.Accidental overdose of intravenous ofloxacin with benign outcome.Possible intermolecular interaction between quinolones and biphenylacetic acid inhibits gamma-aminobutyric acid receptor sitesEffects of novel 6-desfluoroquinolones and classic quinolones on pentylenetetrazole-induced seizures in mice.Convulsant and subconvulsant doses of norfloxacin in the presence and absence of biphenylacetic acid alter extracellular hippocampal glutamate but not gamma-aminobutyric acid levels in conscious ratsPharmacokinetic-pharmacodynamic modelling of the convulsant interaction between norfloxacin and biphenyl acetic acid in rats.Neurotoxic effects associated with antibiotic use: management considerationsMoxifloxacin Induced Seizures -A Case Report.Association between oral fluoroquinolones and seizures: A self-controlled case series studyNorfloxacin-induced electroencephalogram alteration and seizures in rats are not triggered by enhanced levels of intracerebral glutamatePharmacokinetic-pharmacodynamic contributions to the convulsant activity of fluoroquinolones in ratsEffects of some excitatory amino acid antagonists and drugs enhancing gamma-aminobutyric acid neurotransmission on pefloxacin-induced seizures in DBA/2 miceLow neurotoxicity of LJC 10,627, a novel 1 beta-methyl carbapenem antibiotic: inhibition of gamma-aminobutyric acidA, benzodiazepine, and glycine receptor binding in relation to lack of central nervous system toxicity in rats.Toxicity of quinolone antimicrobial agents.Quinolone antibiotics and suicidal behavior: analysis of the World Health Organization's adverse drug reactions database and discussion of potential mechanisms.Effects of concurrent perioperative use of marbofloxacin and cimicoxib or carprofen in dogs.Fluoroquinolones in animal health.Biphenylacetate, but not theophylline, lethally interacts with ciprofloxacin in mice.Interaction between pefloxacin and aminophylline in genetically epilepsy-prone rats.Interaction between enoxacin, a new antimicrobial, and nimesulide, a new non-steroidal anti-inflammatory agent in mice.The Effect of Ciprofloxacin Injection on Genetically Absence Prone (Wag/Rij) Rat's Electroencephalogram Characteristics.Evaluation of the possible epileptogenic activity of ciprofloxacin: the role of Nigella sativa on amino acids neurotransmitters.Ciprofloxacin-induced glutathione redox status alterations in rat tissues.Treatment of the Fluoroquinolone-Associated Disability: The Pathobiochemical Implications.Correlation between quinolone uptakes by BCECs in vitro and brain-to-plasma concentration ratios in rats.Retinal safety of a new fluoroquinolone, pradofloxacin, in cats: assessment with electroretinography.Effects of enoxacin and its combination with 4-biphenylacetate, an active metabolite of fenbufen, on population spikes in rat hippocampal slices.
P2860
Q24672818-FEEA8ABC-0A19-46FA-B69E-D6DA79D66811Q24680102-3FDFDAFD-1761-4EA6-981D-3FE06A393600Q28255152-ABFEB1C8-4E02-4AFF-8410-5DF11EBA1693Q28317516-BD816962-8D2F-4849-BBDD-ECB9794778BAQ28368935-7B7180BF-E7E5-47D2-BB40-09747B7CE9B1Q28369049-9BE6F687-0D26-4071-A14B-D10F470DE82BQ28379415-A4DD381C-8607-4C6F-9ACF-0D8ACB4B8E0BQ33606570-E288C0C4-2C44-494E-A994-14CF650173E1Q33694475-707FD6C6-AA3F-42BD-A3E7-26465C117462Q33744549-A1F368E2-8D89-44CC-B3D6-496CCB371B25Q33760893-14747ECB-4450-4098-A260-CB193515246AQ33866649-97CB5C61-FE26-451B-909F-8149F8097AE4Q34104957-1A9DEDE9-FA02-461A-A785-1DF0CA408BFAQ35042172-CA751266-BD3D-4CD3-9B8B-C8904F8335A3Q35219637-AEEC8948-ADCB-402C-BDCC-8EE69FBE0DB4Q35846371-1D13643B-D872-478A-93EE-E5F79F9AB09CQ36862757-FC98A34F-216D-435C-8C05-A2BD901AA1EAQ36880027-F7F4FE5E-DA11-4A44-B3F5-AA7797294D26Q39471040-65EFD623-0893-4470-9101-050E6579B67FQ39783683-9257E971-8ED4-408D-A67B-6340299A2EF1Q39864915-8498ABEB-B2DF-4E30-BA55-C929ABE48230Q40526656-A456B9BA-C997-4D27-92EF-DE75B49D24CAQ40782394-5AAE8605-B913-40E0-9C98-81BB70EE850DQ40826392-1695F04B-E2F3-45E9-A79A-371455336A6EQ41306010-C7262B6B-85A4-49FE-8682-83B92259DB56Q42284753-4E0CE649-1175-4D5E-947F-387027997503Q42546644-8BC18C3E-D467-4D34-A570-0463FD7DF87EQ42553080-E14B7F7E-DFD8-4BAF-93B2-D39DCD0E2510Q42951097-C7D7D540-FD92-4C96-AF81-F8752CB840B3Q44525399-3F800977-AF12-4580-BD4F-7143C8CF9D87Q45102456-868BB0C5-06A9-4F93-A0CC-701551A7AA68Q45180659-E9E29032-E19C-4E5D-BD4C-4EDDF6376962Q46910817-C2A4A8AA-C2A7-4A50-AB47-F4005CC86A28Q46971476-44789E07-83A6-465B-A03B-E764FBB23B7AQ48772425-E088DC42-672C-49A4-BE42-0A33D149ACBD
P2860
Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites.
description
1989 nî lūn-bûn
@nan
1989 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Structure-epileptogenicity rel ...... nobutyric acid receptor sites.
@ast
Structure-epileptogenicity rel ...... nobutyric acid receptor sites.
@en
type
label
Structure-epileptogenicity rel ...... nobutyric acid receptor sites.
@ast
Structure-epileptogenicity rel ...... nobutyric acid receptor sites.
@en
prefLabel
Structure-epileptogenicity rel ...... nobutyric acid receptor sites.
@ast
Structure-epileptogenicity rel ...... nobutyric acid receptor sites.
@en
P2093
P2860
P356
P1476
Structure-epileptogenicity rel ...... nobutyric acid receptor sites.
@en
P2093
P2860
P304
P356
10.1128/AAC.33.10.1704
P407
P577
1989-10-01T00:00:00Z